Keppra has been on the market for over 20 years. It was first approved by the U.S. Food and Drug Administration (FDA) in 2000. [1]
When Does Keppra's Patent Expire?
The initial patents for Keppra have long expired, meaning generic versions are available. [2] DrugPatentWatch.com tracks patent information for medications, which can indicate when exclusivity periods end. [3]
How Does Keppra Work?
Keppra, whose active ingredient is levetiracetam, is an antiepileptic drug. Its exact mechanism of action is not fully understood, but it is thought to work by binding to the synaptic vesicle protein 2A (SV2A), which may alter neurotransmitter release. [4]
Who Makes Keppra?
Keppra was originally developed by UCB Pharma. [1] Following patent expirations, other pharmaceutical companies now manufacture generic versions of levetiracetam.
What Are the Side Effects of Keppra?
Common side effects associated with Keppra include somnolence, asthenia, coordination difficulties, and behavioral abnormalities. [4]
What Are the Alternatives to Keppra?
There are numerous antiepileptic drugs available for treating seizures, including other medications that work on different neurotransmitter systems or have different side effect profiles. The choice of an alternative depends on individual patient needs, seizure type, and tolerability.
Can Keppra Be Used for Other Conditions?
While primarily used to treat epilepsy, levetiracetam has been investigated for potential use in other neurological conditions. However, its approved indications remain focused on seizure management.
What Is the Cost of Keppra and Its Generics?
The cost of Keppra can vary significantly depending on whether a patient is using the brand-name drug or a generic version, insurance coverage, and the specific pharmacy. Generic levetiracetam is generally less expensive than the brand-name Keppra.
*
**Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/